Using a combinatorial CRISPR-Cas9 screening platform, researchers have demonstrated how this novel two-drug regime can be used in combination with sorafenib to curb tumour cell growth. Accounting for...
On the 100th anniversary of Lipiodol’s introduction as a contrast agent in radiology, research is turning to the role of Lipiodol TACE (cTACE) in combination treatments for Hepatocellular...
A new study finds that the regulation of a particular metabolic mechanism might prevent the malignant transformation of non-alcoholic streatohepatitis into liver cancer. Liver cancer is one of the...
A study by researchers from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences have uncovered the underlying mechanism of how Y-box binding protein 1 promotes cancer...
Interview with Dr Choo Su Pin to shed light on a new generation of therapies that could improve the prognosis of liver cancer patients. Liver cancer is the sixth most common cancer worldwide, which...
Presenting their results at the ESMO Asia Congress in 2019, researchers of the IMbrave150 study show for the first time in a decade a new class of treatment for hepatocellular carcinoma. The study...
IMbrave150 study by Roche shows promise for combination immunotherapy for liver cancer patients. Having first begun in 2018, the IMbrave150 study aimed to study the combination therapy of...
Duke-NUS researchers discover that a specific subset of liver cells can turn into cancer cells and develop into hepatocellular carcinoma. This finding can aid in discovering strategies for effective...
An international team of researchers have found a "one-two punch" method to treat liver cancer by inducing weakness in liver cancer cells and exploiting the vulnerability to reduce tumour growth....
Over 5000 patient data will be used to identify image changes and patterns in liver cancer, helping physicians make better treatment decisions. Lucence Diagnostics, a genomic medicine company in...
New method expected to be more convenient and non-invasive to identify early stage liver cancer. Chinese scientists have designed a new screening method for hepatitis B carriers, to detect...
